Altria Group Inc.

Altria Group Inc.

MO

Get informed when a big investor buys or sells

+ Follow
Market Cap$114.07B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Altria Group Inc.Altria Group Inc.14.46.21%-299%5.3-9.2

Earnings Call Q2 2026

July 30, 2026 - AI Summary

Strong 2Q & 1H performance; guidance raised at the lower end - 2Q adjusted diluted EPS: +$2.8% to $1.48 - 1H adjusted diluted EPS: +$4.9% to $2.80 - 1H shareholder returns: ~$3.9B via dividends + share repurchases - Full-year 2026 adjusted diluted EPS guidance raised (lower end): $5.61–$5.72 (vs $5.42 in 2025; +3.5% to +5.5% growth) - Management attributes confidence to “steady, disciplined execution,” strong smokeable profitability, and a regulatory environment increasingly focused on illicit products.
Smokeable business resilience, with volume declines moderating (but not yet reversing) - 2Q smokeable adjusted OCI: +$2.4% to ~$3.0B; margin: 64.8% (up) - Industry volumes: when adjusted for trade inventory, domestic cigarette volumes estimated -5% in 2Q and -5% in 1H, 4th consecutive quarter of moderated declines - Drivers of improvement: reduced cross-category movement away from cigarettes vs prior periods, helped by supply disruptions/enforcement in illicit flavored e-vapor; still ongoing price elasticity + secular decline and consumer pressure. - Negative/pressure point: consumer affordability remains challenged (inflation, high gas prices, wage lag), driving trade-down dynamics.
Pricing/mix trade-offs: Marlboro holds premium; discount grows share—impacting mix - PM USA profitability: smokable price realization +4.5% in the quarter (driven by net pricing for Marlboro, partially offset by Basic mix as Basic volumes/share rise). - Marlboro premium segment share: 59.6%, essentially flat YoY (steady loyalty). - Basic discount share: +2.3 pts YoY (and +0.3 pts sequentially)—a key reason management focuses on “participate in discount, don’t accelerate” volume growth that could pressure premium profitability.

Exclusive for Stockcircle Pro members

Sign upSign Up
$72.86

Target Price by Analysts

6.7% upsideAltria Group Target Price DetailsTarget Price
$90.27

Current Fair Value

32.2% upside

Undervalued by 32.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$114.07 Billion
Enterprise Value$136.28 Billion
Dividend Yield$4.24 (6.21%)
Earnings per Share$4.11
Beta0.49
Outstanding Shares1,672,000,000

Return

Return on Equity-298.84%ROE
Return on Assets23.89%
Return on Invested Capital44.17%

Valuation & Multiples

P/E Ratio14.41P/E Ratio
PEG-428.38PEG
Price to Sales5.25Price to Sales
Price to Book Ratio-34.13Price to Book Ratio
Enterprise Value to Revenue6.02
Enterprise Value to EBIT12.05
Enterprise Value to Net Income17
Total Debt to Enterprise0.18
Debt to Equity-9.21Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 30, 2026
EPS Estimate
$1.50
Average shareholder expectation
Revenue Estimate
$5.35 B
Average shareholder expectation

Next Earnings Call

Expected Date
October 29, 2026
EPS Estimate
$1.51
Average shareholder expectation
Revenue Estimate
$5.32 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.2950▼ 52.48%
Total Calls26,100▼ 99.79%
Total Puts7,700▼ 99.93%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %3.95%▼ 57.90%
Total Invested$5.08B▼ 92.58%
Investors Holding1,234▼ 1310.00%

ESG Score

No data

About Altria Group Inc.

CEO: William Gifford

Relevant Senate Committees

Joint Committee on Taxation

This committee provides crucial non-partisan analysis and official revenue estimates for all tax legislation. Its technical expertise directly influences the tax policies that are critical to Altria's financial performance and business strategy.

Finance

This powerful committee controls taxation (e.g., federal excise taxes on tobacco products, corporate income tax) and trade policy, which are critically important factors directly impacting Altria's revenue, cost structure, and profitability.

Health, Education, Labor, and Pensions

This committee has direct oversight of the FDA, which is the primary federal regulator for tobacco products. Its decisions profoundly impact Altria's product development, marketing, sales, and new product approvals (e.g., reduced-risk products).